HUE055063T2 - Eljárás magzati kromoszóma aneuploidia nem-invazív azonosítására születés elõtt anyai vérbõl Bayes-háló alapján - Google Patents
Eljárás magzati kromoszóma aneuploidia nem-invazív azonosítására születés elõtt anyai vérbõl Bayes-háló alapjánInfo
- Publication number
- HUE055063T2 HUE055063T2 HUE17748700A HUE17748700A HUE055063T2 HU E055063 T2 HUE055063 T2 HU E055063T2 HU E17748700 A HUE17748700 A HU E17748700A HU E17748700 A HUE17748700 A HU E17748700A HU E055063 T2 HUE055063 T2 HU E055063T2
- Authority
- HU
- Hungary
- Prior art keywords
- bayesian network
- maternal blood
- blood based
- invasive prenatal
- chromosome aneuploidy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Immunology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Databases & Information Systems (AREA)
- Software Systems (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2017/068881 WO2019020180A1 (en) | 2017-07-26 | 2017-07-26 | METHOD FOR NON-EFFECTIVE PRENATAL DETECTION OF FETAL CHROMOSOMAL ANEUPLOIDIE FROM MATERNAL BLOOD ON THE BASIS OF A BAYESIAN NETWORK |
EP17748700.6A EP3658689B1 (en) | 2017-07-26 | 2017-07-26 | A method for non-invasive prenatal detection of fetal chromosome aneuploidy from maternal blood based on bayesian network |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE055063T2 true HUE055063T2 (hu) | 2021-10-28 |
Family
ID=59523092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17748700A HUE055063T2 (hu) | 2017-07-26 | 2017-07-26 | Eljárás magzati kromoszóma aneuploidia nem-invazív azonosítására születés elõtt anyai vérbõl Bayes-háló alapján |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3658689B1 (hu) |
CY (1) | CY1124409T1 (hu) |
EA (1) | EA202090325A1 (hu) |
HR (1) | HRP20210826T1 (hu) |
HU (1) | HUE055063T2 (hu) |
LT (1) | LT3658689T (hu) |
PL (1) | PL3658689T3 (hu) |
SI (1) | SI3658689T1 (hu) |
WO (1) | WO2019020180A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021137770A1 (en) * | 2019-12-30 | 2021-07-08 | Geneton S.R.O. | Method for fetal fraction estimation based on detection and interpretation of single nucleotide variants |
CA3141362A1 (en) * | 2019-12-31 | 2021-07-08 | Bgi Clinical Laboratories (Shenzhen) Co., Ltd. | Method and device for determining chromosomal aneuploidy and constructing classification model |
WO2022035670A1 (en) * | 2020-08-09 | 2022-02-17 | Myriad Women's Health, Inc. | Bayesian sex caller |
CN113012759B (zh) * | 2020-12-09 | 2022-08-12 | 人和未来生物科技(长沙)有限公司 | 一种基于X染色体的男胎cffDNA含量计算方法 |
WO2024049915A1 (en) * | 2022-08-30 | 2024-03-07 | The General Hospital Corporation | High-resolution and non-invasive fetal sequencing |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3770275A1 (en) | 2007-07-23 | 2021-01-27 | The Chinese University of Hong Kong | Determining a fetal aneuploidy |
LT2562268T (lt) | 2008-09-20 | 2017-04-25 | The Board Of Trustees Of The Leland Stanford Junior University | Neinvazinis fetalinės aneuploidijos diagnozavimas sekvenavimu |
EP2824191A3 (en) | 2009-10-26 | 2015-02-18 | Lifecodexx AG | Means and methods for non-invasive diagnosis of chromosomal aneuploidy |
ES2704701T3 (es) | 2010-01-19 | 2019-03-19 | Verinata Health Inc | Nuevo protocolo de preparación de bibliotecas de secuenciación |
JP6153874B2 (ja) * | 2011-02-09 | 2017-06-28 | ナテラ, インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
WO2015026967A1 (en) * | 2013-08-20 | 2015-02-26 | Natera, Inc. | Methods of using low fetal fraction detection |
EP3175000B1 (en) * | 2014-07-30 | 2020-07-29 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP3204512B1 (en) * | 2014-10-10 | 2020-05-06 | Sequenom, Inc. | Methods for partitioning of genomic sequences |
CA2970501C (en) * | 2014-12-12 | 2020-09-15 | Verinata Health, Inc. | Using cell-free dna fragment size to determine copy number variations |
US20160371428A1 (en) * | 2015-06-19 | 2016-12-22 | Natera, Inc. | Systems and methods for determining aneuploidy risk using sample fetal fraction |
-
2017
- 2017-07-26 EP EP17748700.6A patent/EP3658689B1/en active Active
- 2017-07-26 WO PCT/EP2017/068881 patent/WO2019020180A1/en unknown
- 2017-07-26 LT LTEP17748700.6T patent/LT3658689T/lt unknown
- 2017-07-26 EA EA202090325A patent/EA202090325A1/ru unknown
- 2017-07-26 PL PL17748700T patent/PL3658689T3/pl unknown
- 2017-07-26 SI SI201730718T patent/SI3658689T1/sl unknown
- 2017-07-26 HU HUE17748700A patent/HUE055063T2/hu unknown
-
2021
- 2021-05-21 HR HRP20210826TT patent/HRP20210826T1/hr unknown
- 2021-06-22 CY CY20211100548T patent/CY1124409T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP3658689A1 (en) | 2020-06-03 |
CY1124409T1 (el) | 2022-07-22 |
WO2019020180A1 (en) | 2019-01-31 |
LT3658689T (lt) | 2021-06-25 |
PL3658689T3 (pl) | 2021-10-18 |
HRP20210826T1 (hr) | 2021-07-09 |
SI3658689T1 (sl) | 2021-08-31 |
EP3658689B1 (en) | 2021-03-24 |
EA202090325A1 (ru) | 2020-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI3658689T1 (sl) | Metoda za neizvazivno predrojstno zaznavanje anevploidije plodovih kromosomov iz materine krvi na osnovi Bayesove mreže | |
ZA202002204B (en) | Method for increasing fetal hemoglobin expression level | |
HRP20190168T1 (hr) | Metoda neinvazivne prenatalne detekcije aneuploidije kromosoma fetusa iz krvi majke | |
IL260678B (en) | Systems and methods to improve diagnosis of diseases | |
EP3188059A4 (en) | Method for determining patient-specific blood vessel information | |
EP3406189C0 (en) | SYSTEM AND METHOD FOR ESTIMATING HEART RATE | |
WO2017009372A3 (en) | System and methodology for the analysis of genomic data obtained from a subject | |
EP3157416A4 (en) | Method and system for cuff-less blood pressure (bp) measurement of a subject | |
HK1201884A1 (zh) | 同時確定胎兒單體型及染色體非整倍性的方法及裝置 | |
IL266707A (en) | A system, device and method for monitoring and assessing the risk level of the fetus during birth | |
GB201718238D0 (en) | Method and system for determining the disease status of a subject | |
HK1252710A1 (zh) | 用於非侵入性產前測試的靶向基因組區的多重平行分析 | |
EP3347844A4 (en) | METHOD AND SYSTEM FOR DIAGNOSIS OF DISEASES AND FOR THE PREPARATION OF TREATMENT RECOMMENDATIONS | |
EP3731755A4 (en) | SYSTEMS, DEVICES AND METHODS FOR PERFORMING TRANSABDOMINAL FETAL OXIMETRY AND / OR TRANSABDOMINAL FETAL PULSE OXIMETRY WITH INDEPENDENT COMPONENT ANALYSIS | |
IL280538A (en) | Systems and methods for detecting maternal uterine activity | |
GB201609207D0 (en) | Method and system for predicting heart tissue activation | |
EP3735181C0 (en) | SYSTEM FOR DETERMINING PERIPHERAL ARTERIAL DISEASE | |
PT3311174T (pt) | Método para o diagnóstico dos distúrbios causados pelo alcoolismo fetal | |
WO2013173499A3 (en) | Diagnostic methods and devices for monitoring chronic glycemia | |
EP3125771A4 (en) | System and method for predicting fetal and maternal health risks | |
EP3238618A4 (en) | Muscle area estimation system and instrument, and method for estimating muscle area | |
EP3702784A4 (en) | BLOOD-BASED CANCER DIAGNOSIS METHOD | |
ZA201607324B (en) | Non-invasive diagnostic method for the early detection of fetal malformations | |
GB201618027D0 (en) | Method for blind extraction of fetal electrocardio based on time-frequency conversion | |
IL272484A (en) | Systems and methods for improving disease diagnosis using measured test substances |